$0.7375
al cierre: Oct 29 EDT
$0.7374
-0.000100-0.01%
Pre-comercialización: 5:19 AM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Cue Biopharma informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
nov 13
Estimación de BPA
$-0.090
Estimación de ingresos trimestrales
$2.37M
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$8.29M
Analice el historial de beneficios de Cue Biopharma utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
CUE | Cue Biopharma | -$0.17 | -$0.09 | — | — | $3.34M | $2.37M | — | — | 11/13/2025 | |
CUE | Cue Biopharma | -$0.20 | -$0.13 | -$0.09 | 30.77% | $2.66M | $2.00M | $2.95M | 47.70% | 08/12/2025 | |
CUE | Cue Biopharma | -$0.25 | -$0.12 | -$0.17 | -41.67% | $1.72M | $901.50K | $421.00K | -53.30% | 05/12/2025 | |
CUE | Cue Biopharma | -$0.29 | -$0.14 | -$0.13 | 7.14% | $1.82M | $1.70M | $1.58M | -7.29% | 03/31/2025 | |
CUE | Cue Biopharma | -$0.24 | -$0.19 | -$0.17 | 10.53% | $2.10M | $1.52M | $3.34M | 119.47% | 11/14/2024 | |
CUE | Cue Biopharma | -$0.29 | -$0.29 | -$0.20 | 31.03% | $1.38M | $1.29M | $2.66M | 106.05% | 08/14/2024 | |
CUE | Cue Biopharma | -$0.29 | -$0.28 | -$0.25 | 10.71% | $187.00K | $1.21M | $1.72M | 41.90% | 05/09/2024 | |
CUE | Cue Biopharma | -$0.37 | -$0.28 | -$0.28 | 0.00% | $151.00K | $1.71M | $1.82M | 6.49% | 04/08/2024 | |
CUE | Cue Biopharma | -$0.31 | -$0.34 | -$0.24 | 29.41% | $68.00K | $1.13M | $2.10M | 85.84% | 11/03/2023 | |
CUE | Cue Biopharma | -$0.37 | -$0.30 | -$0.29 | 3.33% | $26.00K | $1.21M | $1.38M | 14.21% | 08/09/2023 | |
CUE | Cue Biopharma | -$0.44 | -$0.29 | -$0.29 | 0.00% | $1.00M | $1.95M | $187.00K | -90.41% | 05/09/2023 | |
CUE | Cue Biopharma | -$0.25 | -$0.31 | -$0.37 | -19.35% | $8.25M | $100.00K | $151.00K | 51.00% | 03/21/2023 | |
CUE | Cue Biopharma | -$0.41 | -$0.38 | -$0.31 | 18.42% | $2.40M | $440.00K | $68.00K | -84.55% | 11/14/2022 | |
CUE | Cue Biopharma | -$0.33 | -$0.42 | -$0.37 | 11.90% | $2.74M | — | $26.00K | — | 08/04/2022 | |
CUE | Cue Biopharma | -$0.41 | -$0.43 | -$0.44 | -2.33% | $1.55M | $3.05M | $1.00M | -67.21% | 05/10/2022 | |
CUE | Cue Biopharma | -$0.36 | -$0.38 | -$0.25 | 34.21% | $475.00K | — | $8.25M | — | 03/16/2022 | |
CUE | Cue Biopharma | -$0.34 | -$0.39 | -$0.41 | -5.13% | $704.00K | — | $2.40M | — | 10/27/2021 | |
CUE | Cue Biopharma | -$0.38 | -$0.42 | -$0.33 | 21.43% | $1.07M | $1.06M | $2.74M | 158.40% | 08/17/2021 | |
CUE | Cue Biopharma | -$0.48 | -$0.38 | -$0.41 | -7.89% | $900.00K | — | $1.55M | — | 05/17/2021 | |
CUE | Cue Biopharma | -$0.37 | -$0.35 | -$0.37 | -5.71% | $1.05M | $1.33M | $475.00K | -64.29% | 03/16/2021 | |
CUE | Cue Biopharma | -$0.31 | — | -$0.34 | — | $984.00K | — | $704.00K | — | 11/09/2020 |
Cue Biopharma (CUE) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-12 | $-0.09 | $-0.13 | 30.8 % |
| Q1 | 2025-05-12 | $-0.17 | $-0.12 | -41.7 % |
| Q4 | 2025-03-31 | $-0.13 | $-0.14 | 7.14 % |
| Q3 | 2024-11-14 | $-0.17 | $-0.19 | 10.5 % |
Cue Biopharma (CUE) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-12 | $2.95M | $2.00M | 47.7 % |
| Q1 | 2025-05-12 | $421.00K | $901.50K | -53.3 % |
| Q4 | 2025-03-31 | $1.58M | $1.70M | -7.29 % |
| Q3 | 2024-11-14 | $3.34M | $1.52M | 119.5 % |
PREGUNTAS FRECUENTES
¿Cuándo Cue Biopharma (NASDAQ:CUE) publicará los resultados?
Está previsto que Cue Biopharma (CUE) presente resultados el noviembre 13, 2025. Los últimos resultados se publicaron el agosto 12, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Cue Biopharma (NASDAQ:CUE)?
El BPA real fue de $-0.09, que superó la estimación de $-0.13.
¿Cuáles fueron los ingresos de Cue Biopharma (NASDAQ:CUE)?
Los ingresos reales fueron $3M, que superó la estimación de $2M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.